Who invested in Xencor?
Xencor's investors include Oxford Bioscience Partners, Novo Nordisk and Merlin Nexus.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$36Mraised across 4 rounds since 2007, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $7.6M sold, first sale Jun 2013
No investor was named in the report.
From a historical funding recordSEC filing: $7.5M sold, first sale Dec 2010
No investor was named in the report.
From a historical funding recordSEC filing: $6.0M sold, first sale Mar 2009
From Xencor's own website and the SEC filings it signed: 8 on the team.
On the board, as filediA. Bruce MontgomeryDagmar Bruce Rosa-BjorkesonEllen FeigalKevin GormanKurt GustafsonRichard Bruce RanieriYujiro Hata
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Xencor's investors include Oxford Bioscience Partners, Novo Nordisk and Merlin Nexus.
Xencor has raised $36M across 4 rounds since 2007.
Xencor's most recent round was a Venture of $7.6M in Jul 2013.
Xencor's largest round on record is $15M (Series E), in Oct 2007.
Xencor's first round on record, in Oct 2007, was backed by Oxford Bioscience Partners, Novo Nordisk and Merlin Nexus.
Xencor's latest named round is a Venture, in Jul 2013.
Xencor is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.